- Home
- DFH vs AMPH Comparison
DFH vs AMPH Comparison
Compare DFH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFH
- AMPH
- Stock Information
- Founded
- DFH 2008
- AMPH 1996
- Country
- DFH United States
- AMPH United States
- Employees
- DFH N/A
- AMPH N/A
- Industry
- DFH Homebuilding
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- DFH Consumer Discretionary
- AMPH Health Care
- Exchange
- DFH Nasdaq
- AMPH Nasdaq
- Market Cap
- DFH 3.1B
- AMPH 2.5B
- IPO Year
- DFH 2021
- AMPH 2014
- Fundamental
- Price
- DFH $28.30
- AMPH $44.61
- Analyst Decision
- DFH Hold
- AMPH Buy
- Analyst Count
- DFH 1
- AMPH 4
- Target Price
- DFH $38.00
- AMPH $63.00
- AVG Volume (30 Days)
- DFH 438.5K
- AMPH 386.5K
- Earning Date
- DFH 10-31-2024
- AMPH 11-06-2024
- Dividend Yield
- DFH N/A
- AMPH N/A
- EPS Growth
- DFH 15.80
- AMPH 17.38
- EPS
- DFH 3.03
- AMPH 3.01
- Revenue
- DFH $4,028,851,000.00
- AMPH $723,549,000.00
- Revenue This Year
- DFH $15.83
- AMPH $17.23
- Revenue Next Year
- DFH N/A
- AMPH $10.25
- P/E Ratio
- DFH $9.29
- AMPH $14.82
- Revenue Growth
- DFH 8.59
- AMPH 20.33
- 52 Week Low
- DFH $23.46
- AMPH $36.56
- 52 Week High
- DFH $44.38
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- DFH 34.60
- AMPH 36.64
- Support Level
- DFH $30.55
- AMPH $50.04
- Resistance Level
- DFH $33.26
- AMPH $49.53
- Average True Range (ATR)
- DFH 1.54
- AMPH 1.75
- MACD
- DFH -0.30
- AMPH -0.78
- Stochastic Oscillator
- DFH 5.97
- AMPH 7.24
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.